US 11926661
Human antibodies to artemin and methods of use thereof
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 11926661 (Human antibodies to artemin and methods of use thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61P, A61P25/00